<DOC>
	<DOCNO>NCT03072472</DOCNO>
	<brief_summary>This study aim assess effect , , adenoma detection rate BowelScope bowel cancer screen flexible sigmoidoscopy use Endocuff Vision device .</brief_summary>
	<brief_title>BowelScope : Accuracy Detection Using ENdocuff Optimisation Mucosal Abnormalities</brief_title>
	<detailed_description>Colorectal cancer ( CRC ) fourth common cancer UK 40,000 new case diagnose annually . Most CRCs arise adenoma-carcinoma sequence process take 10 year . Population screen programme allow early detection removal adenoma may become malignant time thus reduce CRC mortality . The English Bowel Scope Screening ( BSS ) programme begin 2013 invite adult age 55 one-off flexible sigmoidoscopy . The aim BSS programme reduce CRC development via adenoma-carcinoma sequence detection removal adenoma leave side colon . A large UK study show offer one-off flexible sigmoidoscopy screen adenoma clearance adult age 55-64 year reduce CRC incidence 23 % mortality 31 % . Adenoma detection rate ( ADR ) important marker mucosal visualisation surrogate marker high quality colonoscopy . Data colonoscopy study illustrate 1 % increase ADR associate 3 % decrease interval colorectal cancer . In BSS programme , ADR comparatively low show initial sigmoidoscopy screen trial wide variation endoscopists . Another marker often use adenoma miss rate also demonstrate wide variation clinical practice . Reasons lesion detect flexible sigmoidoscopy extrapolate colonoscopy data include ; suboptimal technique ; short withdrawal time ; inadequate bowel preparation ; presence flat , depressed subtle lesion ; inability visualise proximal side haustral fold , flexure ( blind spot ) rectal valve . With aid colonoscopic cuff Endocuff Vision® , investigator aim improve visualisation colonic mucosa flatten colonic fold manipulate away field forward view investigator hypothesise Endocuff Vision® improve adenoma detection rate provide well fold retraction , wide field view well scope tip stabilisation . This clinical randomise study conduct subject refer schedule screen flexible sigmoidoscopy via NHS English Bowel Scope Screening ( BSS ) Programme compare Endocuff Vision®-Assisted Flexible Sigmoidoscopy ( EAFS ) Standard Flexible Sigmoidoscopy ( SFS ) .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Polyps</mesh_term>
	<mesh_term>Adenoma</mesh_term>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Colonic Polyps</mesh_term>
	<mesh_term>Colonic Diseases</mesh_term>
	<mesh_term>Intestinal Diseases</mesh_term>
	<mesh_term>Rectal Diseases</mesh_term>
	<mesh_term>Intestinal Neoplasms</mesh_term>
	<mesh_term>Digestive System Neoplasms</mesh_term>
	<mesh_term>Gastrointestinal Neoplasms</mesh_term>
	<mesh_term>Neoplasms , Glandular Epithelial</mesh_term>
	<mesh_term>Digestive System Diseases</mesh_term>
	<mesh_term>Gastrointestinal Diseases</mesh_term>
	<mesh_term>Pathological Conditions , Anatomical</mesh_term>
	<mesh_term>Intestinal Polyps</mesh_term>
	<criteria>1 . Age 18 year 2 . Referral screen flexible sigmoidoscopy 3 . Ability give inform consent 1 . Absolute contraindication flexible sigmoidoscopy 2 . Established suspicion large bowel obstruction pseudoobstruction 3 . Known colon cancer polyposis syndromes 4 . Known colonic stricture 5 . Known severe diverticular segment ( likely impede sigmoidoscope passage ) 6 . Patients know active colitis ( ulcerative colitis , Crohn 's colitis , diverticulitis , infective colitis ) 7 . Patients lack capacity give inform consent 8 . Patients clopidogrel , warfarin , new generation anticoagulant stop procedure preclude polyp removal 9 . Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>61 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Colorectal Cancer</keyword>
	<keyword>Endoscopy</keyword>
	<keyword>Screening</keyword>
	<keyword>Colonic Adenoma</keyword>
	<keyword>Adenoma Detection Rate</keyword>
	<keyword>Endocuff</keyword>
	<keyword>Endocuff Vision</keyword>
</DOC>